Longevity

Longevity Daily: 31st August, 2020

Posted on 31 August 2020

Everyday our team of researchers in Oxford are inundated with scientific, and medical research articles that have the potential to improve health, wellbeing, and longevity. In this blog we highlight a few of them that caught our attention today.

The University of Wisconsin (UW) study found that rhesus monkeys that were fed a calorie-restricted diet, which contained 30% fewer calories than a control group’s diet, lived an average of 3 yrs longer, and remained on average healthier than their peers consuming more calories. Source https://www.nia.nih.gov/news/calorie-restriction-improves-health-survival-rhesus-monkeys
  1. Can eating a bit less increase our lifespan, and improve our health?
  2. What is the fast(est) way to improve our health and live long?
    • Why is this important: From the study mentioned above we learnt that we can lose weight, and become healthier by eat 15% less for two or more years. But most of us do not have the will power, or patience to keep up our calorie restricted diet for years. Is there a faster way to gain all the benefits of calorie restriction?
    • What did the researchers do: Researchers from Italy, Germany and the US studied 71 participants for about 2 years on a fasting mimicking diet. The participants did only 5 consecutive days of fasting mimicking diet each month for 3 months, and the rest of the time they ate normally. The fasting mimicking diet provided between 700 to 1000 Calories per day, and all the necessary vitamins, macro- and micronutrients.
    • Key takeaway(s): The researchers found right after completing three-months of just 5-day fasting mimicking diets the participants lost weight, reduced fat, lowered their blood pressure, and decreased harmful growth factors in their blood. A longer term analysis of these participants showed that just by doing a few 5-day fasting mimicking diets a years people might be able to lose weight, reducing their blood pressure, reduce their blood sugar levels, reduce their cholesterol levels, and reduce their markers for harmful inflammation.

  3. Can microbes in the gut contribute to brain aging?
    • Why is this important: We know that cognitive decline during aging is partly caused by increased inflammation in the brain. We also know that bacteria in the gut can have a profound effect on both the immune system and the central nervous system. The gut microbiome may therefore modulate cognitive decline.
    • What did the researchers do: Here, researchers investigated the role a molecule produced by gut microbes, called trimethylamine N-oxide (TMAO), in modulating inflammation and cognitive function in the aging brain.
    • Key takeaway(s): In humans, higher levels of TMAO correlated with poorer cognitive performance. In mice, TMAO levels increased with age and were associated with higher brain inflammation, and mice that were given TMAO in their food had more inflammation and poorer cognitive function. The study suggests TMAO might be a promising target for preventing cognitive decline.

  4. CRISPR gene therapy prevents obesity and metabolic syndrome caused by a high calorie diet in mice
    • Why is this important: In adults, adipose tissue consists largely of regular white adipose tissue (WAT), which is adept at storing calories. It is the expansion of these WAT cells, due to a high calorie diet, which is one of the causes of obesity, type 2 diabetes and high blood pressure, otherwise known as metabolic syndrome. Unlike WAT, mitochondria-packed, brown adipose tissue (BAT) burns more energy, meaning less calories are hoarded, and the risk of obesity, and therefore metabolic syndrome, is reduced. Finding a way to convert WAT to express a metabolic phenotype more closely resembling BAT would be a very promising way in which to battle obesity and metabolic disease. This is exactly what this study aimed to do.
    • What did the researchers do: Researchers utilised CRISPR-Cas9 gene editing technology to engineer the WAT of mice to over-express uncoupling protein 1 (UCP1). UCP1 plays a major role in the metabolic phenotype of brown adipose tissue. Genetically engineering WAT cells to over-express UCP1 results in WAT acquiring the thermogenic characteristics of BAT.
    • Key takeaway(s): Obese mice which received this treatment presented improvements in glucose tolerance, insulin sensitivity and increased energy expenditure. This data shows promising evidence for the CRISPR-engineered cell therapy being a potential therapy to combat obesity and metabolic syndrome.

Recommended Products


Featured in This Post
Topics

Never Miss a Breakthrough!

Sign up for our newletter and get the latest breakthroughs direct to your inbox.

Checkout the Gowing Life Store

Scientifically Developed Blended Vitamins, and Exclusive Supplements For Health, and Longevity

Copyright © Gowing Life Limited, 2022 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.